Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, March 10, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that U.S. FDA...
-
VANCOUVER, British Columbia, March 10, 2024 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V und ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (das „Unternehmen“) gab heute die offizielle Aufnahme seines...
-
VANCOUVER, British Columbia, March 10, 2024 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company") today announced that its Chvaletice Manganese...
-
BRISBANE, Australia, March 08, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or “the Company”), a leading battery materials and technology company, today announced that...
-
Highlights: Immuron proceeding to Phase 3 registration strategy with the FDATravelan® topline clinical trial results demonstrate protective efficacy with single daily dose36.4% protective efficacy...
-
TORONTO, March 06, 2024 (GLOBE NEWSWIRE) -- This notice is given by Xanadu Mines Ltd (ACN 1144 249 026) (Xanadu Mines or the Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth)...
-
TORONTO, March 06, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased to update on metallurgical testwork for the Kharmagtai Project in Mongolia,...
-
ResMed unveils the AirFit F40, an ultra-compact full-face CPAP mask offering the comfort of smaller masks without sacrificing performance.
-
MELBOURNE, Australia, March 05, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT; “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly...
-
Data from the safety lead-in of the AIPAC-003 trial shows 90mg efti in combination with paclitaxel is safe and well toleratedEncouraging initial efficacy in six metastatic breast cancer patients, who...